Stock Earnings

Question 1

Recursion Pharmaceuticals Inc 的关键财务报表是什么？

Accepted Answer

根据最新的财务报表（Form-10K），Recursion Pharmaceuticals Inc 的总资产为 $1,448，净loss为 $-463

Question 2

RXRX 的关键财务比率是什么？

Accepted Answer

Recursion Pharmaceuticals Inc 的流动比率是 3.5，净利 margin 为 -798.27，每股销售为 $0.21。

Question 3

Recursion Pharmaceuticals Inc 的收入按细分市场或地理位置如何划分？

Accepted Answer

Recursion Pharmaceuticals Inc largest revenue segment is Drug Discovery, at a revenue of 58,839,000 in the most earnings release.For geography, United States is the primary market for Recursion Pharmaceuticals Inc, at a revenue of 58,839,000.

Question 4

Recursion Pharmaceuticals Inc 是否盈利？

Accepted Answer

no，根据最新的财务报表，Recursion Pharmaceuticals Inc 的净loss为 $-463

Question 5

Recursion Pharmaceuticals Inc 有负债吗？

Accepted Answer

yes，Recursion Pharmaceuticals Inc 的负债为 413

Question 6

Recursion Pharmaceuticals Inc 的流通股有多少？

Accepted Answer

Recursion Pharmaceuticals Inc 的总流通股为 396.5

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	64	58	44	39	10	3
Revenue Growth (YoY)	31%	32%	13%	290%	233%	50%
Cost of Revenue	66	45	42	48	--	--
Gross Profit	-2	13	1	-8	--	--
Selling, General & Admin	216	178	133	95	66	27
Research & Development	419	295	208	141	125	61
Operating Expenses	647	492	350	237	192	88
Other Non Operating Income (Expenses)	-7	0	-1	0	0	0
Pretax Income	-649	-464	-332	-239	-186	-87
Income Tax Expense	0	-1	-4	--	--	--
Net Income	-649	-463	-328	-239	-186	-87
Net Income Growth	74%	41%	37%	28%	113.99%	43%
Shares Outstanding (Diluted)	417.36	274.2	207.85	175.54	125.35	162.16
Shares Change (YoY)	72%	32%	18%	40%	-23%	0%
EPS (Diluted)	-1.55	-1.69	-1.57	-1.36	-1.49	-0.54
EPS Growth	1%	7%	16%	-9%	176%	42%
Free Cash Flow	-393	-372	-299	-120	-198	-51
Free Cash Flow Per Share	-0.94	-1.35	-1.43	-0.68	-1.57	-0.31
Gross Margin	-3.12%	22.41%	2.27%	-20.51%	--	--
Operating Margin	-1,014.06%	-825.86%	-790.9%	-628.2%	-1,820%	-2,800%
Profit Margin	-1,014.06%	-798.27%	-745.45%	-612.82%	-1,860%	-2,900%
Free Cash Flow Margin	-614.06%	-641.37%	-679.54%	-307.69%	-1,980%	-1,700%
EBITDA	-586	-443	-324	-234	-174	-80
EBITDA Margin	-915.62%	-763.79%	-736.36%	-600%	-1,739.99%	-2,666.66%
D&A For EBITDA	63	36	24	11	8	4
EBIT	-649	-479	-348	-245	-182	-84
EBIT Margin	-1,014.06%	-825.86%	-790.9%	-628.2%	-1,820%	-2,800%
Effective Tax Rate	0%	0.21%	1.2%	--	--	--

Recursion Pharmaceuticals Inc (RXRX) Price

RXRX Stock Price Chart

RXRX Income

Follow-Up Questions